PK-RNN-V E: A deep learning model approach to vancomycin therapeutic drug monitoring using electronic health record data
- 17 August 2022
- journal article
- research article
- Published by Elsevier in Journal of Biomedical Informatics
- Vol. 133, 104166
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Cancer Prevention and Research Institute of Texas (RP160015, RP210042)
- University of Texas Health Science Center at Houston
This publication has 18 references indexed in Scilit:
- Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulationJournal of Clinical Pharmacy and Therapeutics, 2014
- Vancomycin: Over 50 Years Later and Still a Work in ProgressPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patientsJournal of Clinical Pharmacy and Therapeutics, 2013
- Vancomycin therapeutics and monitoring: a contemporary approachInternal Medicine Journal, 2013
- Waves of resistance: Staphylococcus aureus in the antibiotic eraNature Reviews Microbiology, 2009
- Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parametersAmerican Journal of Health-System Pharmacy, 2006
- The Pharmacokinetic and Pharmacodynamic Properties of VancomycinClinical Infectious Diseases, 2006
- Population Pharmacokinetic Analysis of Vancomycin in Patients with Hematological MalignanciesAntimicrobial Agents and Chemotherapy, 2005
- A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible?Journal of Internal Medicine, 1999
- Studies in the concentration of indifferent narcotics in blood and tissuesActa Medica Scandinavica, 1919